$1.42
5.97% yesterday
Nasdaq, Nov 25, 10:17 pm CET
ISIN
US88688T1007
Symbol
TLRY
Sector
Industry

Tilray, Inc. Series 2 Stock price

$1.42
-0.27 15.98% 1M
-0.43 23.24% 6M
-0.88 38.26% YTD
-0.35 19.77% 1Y
-9.48 86.97% 3Y
-19.37 93.17% 5Y
-20.97 93.66% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
+0.08 5.97%
ISIN
US88688T1007
Symbol
TLRY
Sector
Industry

Key metrics

Market capitalization $1.28b
Enterprise Value $1.40b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.72
P/S ratio (TTM) P/S ratio 1.58
P/B ratio (TTM) P/B ratio 0.36
Revenue growth (TTM) Revenue growth 24.76%
Revenue (TTM) Revenue $812.04m
EBIT (operating result TTM) EBIT $-118.26m
Free Cash Flow (TTM) Free Cash Flow $-81.70m
Cash position $280.06m
EPS (TTM) EPS $-0.27
P/E forward negative
P/S forward 1.41
EV/Sales forward 1.54
Short interest 12.56%
Show more

Is Tilray, Inc. Series 2 a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Tilray, Inc. Series 2 Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Tilray, Inc. Series 2 forecast:

4x Buy
29%
10x Hold
71%

Analyst Opinions

14 Analysts have issued a Tilray, Inc. Series 2 forecast:

Buy
29%
Hold
71%

Financial data from Tilray, Inc. Series 2

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Aug '24
+/-
%
812 812
25% 25%
100%
- Direct Costs 658 658
9% 9%
81%
155 155
219% 219%
19%
- Selling and Administrative Expenses 144 144
36% 36%
18%
- Research and Development Expense 0.66 0.66
10% 10%
0%
9.68 9.68
117% 117%
1%
- Depreciation and Amortization 128 128
1% 1%
16%
EBIT (Operating Income) EBIT -118 -118
36% 36%
-15%
Net Profit -213 -213
85% 85%
-26%

In millions USD.

Don't miss a Thing! We will send you all news about Tilray, Inc. Series 2 directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Tilray, Inc. Series 2 Stock News

Neutral
GlobeNewsWire
19 minutes ago
Craft flower enthusiasts can now experience the handcrafted excellence and superior genetics of Broken Coast cannabis' latest release: Platinum Pavé.
Neutral
The Motley Fool
2 days ago
The outcome of elections can shape policies and decisions for years to come, and it's no exception in the U.S. Following Donald Trump's election as the 47th president of the United States and Republicans gaining control of the Senate and the House of Representatives, some companies and industries could potentially benefit from the change in administration at the national level. Others, not so m...
Neutral
GlobeNewsWire
5 days ago
SEATTLE, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Redhook Ale Brewery (“Redhook”), Seattle's pioneering craft brewery and a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), officially presents their new partnership with the Montlake Futures NIL Collective, supporting student-athletes at the University of Washington (UW). Together, they launched Montlake Gameday Gold Lager, the Official ...
More Tilray, Inc. Series 2 News

Company Profile

Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment sales consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment sales consist of hemp seed, hemp foods, board spectrum hemp extract containing CBD which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.

Head office United States
CEO Irwin Simon
Employees 2,650
Founded 2018
Website www.tilray.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today